Salma Jabbour
Associate Director for Faculty Affairs and Development · Rutgers Health
Credentials: · · ·
History
- Present
- Present
Radiation Oncology at RWJUH & Rutgers Cancer Institute Division · Rutgers Health
- Present
- 2001–2002
Preliminary or Transitional Year
Research
Clinical Cancer Research · 2016 · 317 citations
ESMO Open · 2022 · 289 citations
The Lancet Oncology · 2022 · 226 citations
40 papers · 14 as a resident
- JM
32 papers · 1 as a fellow
- JA
26 papers
23 papers
- NY
23 papers · 9 as a resident
22 papers
22 papers
- CS
18 papers
Grants
- 2026–2032
Clinical Trial Support for the Rutgers Cancer Institute and the RWJBarnabas Health System
National Cancer Institute · UG1
PI · $1.2M · Rutgers Biomedical and Health Sciences
- 1997–2029
National Cancer Institute · P30
Project lead · $684.3K · Rutgers Biomedical and Health Sciences
- 2023–2028
Dr. Salma Jabbour’s NCI Research Specialist (Clinician Scientist) Award (R50)
National Cancer Institute · R50
Contact PI · $784.7K · Rutgers Biomedical and Health Sciences
- 2014–2027
Clinical trials
- 2024–2028
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Principal investigator · Withdrawn · Phase 1
Rutgers, The State University of New Jersey
- 2022–2027
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
Principal investigator · Recruiting · Phase 2
Rutgers, The State University of New Jersey
- 2022–2028
Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer
Principal investigator · Suspended · Phase 2
Rutgers, The State University of New Jersey
- 2021–2027
Principal investigator · Active not recruiting
Rutgers, The State University of New Jersey